CHORUS AVIATION INC (CHR.CA) Stock Fundamental Analysis
TSX:CHR - Toronto Stock Exchange - CA17040T8885 - Common Stock - Currency: CAD
We assign a fundamental rating of 5 out of 10 to CHR. CHR was compared to 8 industry peers in the Passenger Airlines industry. Both the profitability and the financial health of CHR get a neutral evaluation. Nothing too spectacular is happening here. CHR is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
In the past year CHR was profitable.
CHR had a positive operating cash flow in the past year.
In multiple years CHR reported negative net income over the last 5 years.
CHR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CHR has a Return On Assets of -16.53%. This is in the lower half of the industry: CHR underperforms 62.50% of its industry peers.
CHR's Return On Equity of -51.90% is on the low side compared to the rest of the industry. CHR is outperformed by 62.50% of its industry peers.
With an excellent Return On Invested Capital value of 6.82%, CHR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
CHR had an Average Return On Invested Capital over the past 3 years of 5.30%. This is in line with the industry average of 6.00%.
The last Return On Invested Capital (6.82%) for CHR is above the 3 year average (5.30%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -16.53% | ||
| ROE | -51.9% | ||
| ROIC | 6.82% |
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
1.3 Margins
CHR has a Operating Margin of 6.78%. This is in the better half of the industry: CHR outperforms 62.50% of its industry peers.
CHR's Operating Margin has declined in the last couple of years.
CHR's Gross Margin of 64.61% is amongst the best of the industry. CHR outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of CHR has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.78% | ||
| PM (TTM) | N/A | ||
| GM | 64.61% |
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHR is destroying value.
The number of shares outstanding for CHR has been reduced compared to 1 year ago.
CHR has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CHR has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.62, we must say that CHR is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CHR (0.62) is worse than 62.50% of its industry peers.
The Debt to FCF ratio of CHR is 2.43, which is a good value as it means it would take CHR, 2.43 years of fcf income to pay off all of its debts.
CHR's Debt to FCF ratio of 2.43 is amongst the best of the industry. CHR outperforms 100.00% of its industry peers.
A Debt/Equity ratio of 0.55 indicates that CHR is somewhat dependend on debt financing.
CHR has a better Debt to Equity ratio (0.55) than 87.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 2.43 | ||
| Altman-Z | 0.62 |
ROIC/WACC0.85
WACC8.06%
2.3 Liquidity
CHR has a Current Ratio of 0.95. This is a bad value and indicates that CHR is not financially healthy enough and could expect problems in meeting its short term obligations.
CHR has a Current ratio of 0.95. This is in the better half of the industry: CHR outperforms 62.50% of its industry peers.
A Quick Ratio of 0.69 indicates that CHR may have some problems paying its short term obligations.
The Quick ratio of CHR (0.69) is worse than 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.69 |
3. Growth
3.1 Past
CHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 263.33%, which is quite impressive.
CHR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.95% yearly.
CHR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.43%.
Measured over the past years, CHR shows a small growth in Revenue. The Revenue has been growing by 0.56% on average per year.
EPS 1Y (TTM)263.33%
EPS 3Y43.35%
EPS 5Y11.95%
EPS Q2Q%1100%
Revenue 1Y (TTM)-16.43%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-16.21%
3.2 Future
The Earnings Per Share is expected to grow by 15.78% on average over the next years. This is quite good.
The Revenue is expected to grow by 0.78% on average over the next years.
EPS Next Y106.63%
EPS Next 2Y30.22%
EPS Next 3Y15.78%
EPS Next 5YN/A
Revenue Next Year-1.8%
Revenue Next 2Y-1.4%
Revenue Next 3Y0.78%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 17.46 indicates a rather expensive valuation of CHR.
75.00% of the companies in the same industry are more expensive than CHR, based on the Price/Earnings ratio.
CHR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.22.
With a Price/Forward Earnings ratio of 8.45, the valuation of CHR can be described as very reasonable.
Based on the Price/Forward Earnings ratio, CHR is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of CHR to the average of the S&P500 Index (20.86), we can say CHR is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.46 | ||
| Fwd PE | 8.45 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHR indicates a rather cheap valuation: CHR is cheaper than 87.50% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CHR is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.38 | ||
| EV/EBITDA | 3.77 |
4.3 Compensation for Growth
CHR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CHR's earnings are expected to grow with 15.78% in the coming years.
PEG (NY)0.16
PEG (5Y)1.46
EPS Next 2Y30.22%
EPS Next 3Y15.78%
5. Dividend
5.1 Amount
No dividends for CHR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:CHR (5/1/2025, 7:00:00 PM)
19.03
+0.4 (+2.15%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)
Earnings (Next)
Inst Owners1.95%
Inst Owner ChangeN/A
Ins Owners1.18%
Ins Owner ChangeN/A
Market Cap504.68M
Analysts78.18
Price Target27.36 (43.77%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-10.08%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)116.73%
Min EPS beat(2)25.51%
Max EPS beat(2)207.96%
EPS beat(4)3
Avg EPS beat(4)41.76%
Min EPS beat(4)-80.2%
Max EPS beat(4)207.96%
EPS beat(8)3
Avg EPS beat(8)6.63%
EPS beat(12)4
Avg EPS beat(12)0%
EPS beat(16)7
Avg EPS beat(16)1.16%
Revenue beat(2)0
Avg Revenue beat(2)-5.87%
Min Revenue beat(2)-7.96%
Max Revenue beat(2)-3.78%
Revenue beat(4)1
Avg Revenue beat(4)-4.04%
Min Revenue beat(4)-10.27%
Max Revenue beat(4)5.86%
Revenue beat(8)4
Avg Revenue beat(8)-1.07%
Revenue beat(12)6
Avg Revenue beat(12)0.32%
Revenue beat(16)9
Avg Revenue beat(16)5.8%
PT rev (1m)-2.7%
PT rev (3m)600.55%
EPS NQ rev (1m)-3.66%
EPS NQ rev (3m)676.19%
EPS NY rev (1m)0%
EPS NY rev (3m)636.31%
Revenue NQ rev (1m)-0.33%
Revenue NQ rev (3m)1.03%
Revenue NY rev (1m)0.5%
Revenue NY rev (3m)-0.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.46 | ||
| Fwd PE | 8.45 | ||
| P/S | 0.36 | ||
| P/FCF | 2.38 | ||
| P/OCF | 1.9 | ||
| P/B | 0.99 | ||
| P/tB | 1 | ||
| EV/EBITDA | 3.77 |
EPS(TTM)1.09
EY5.73%
EPS(NY)2.25
Fwd EY11.84%
FCF(TTM)8
FCFY42.03%
OCF(TTM)9.99
OCFY52.51%
SpS52.98
BVpS19.3
TBVpS18.97
PEG (NY)0.16
PEG (5Y)1.46
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -16.53% | ||
| ROE | -51.9% | ||
| ROCE | 9.2% | ||
| ROIC | 6.82% | ||
| ROICexc | 8.69% | ||
| ROICexgc | 8.78% | ||
| OM | 6.78% | ||
| PM (TTM) | N/A | ||
| GM | 64.61% | ||
| FCFM | 15.1% |
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexcg growth 3Y33.52%
ROICexcg growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score6
Asset Turnover0.87
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 2.43 | ||
| Debt/EBITDA | 1.34 | ||
| Cap/Depr | 45.44% | ||
| Cap/Sales | 3.76% | ||
| Interest Coverage | 1.21 | ||
| Cash Conversion | 125.19% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.69 | ||
| Altman-Z | 0.62 |
F-Score6
WACC8.06%
ROIC/WACC0.85
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)263.33%
EPS 3Y43.35%
EPS 5Y11.95%
EPS Q2Q%1100%
EPS Next Y106.63%
EPS Next 2Y30.22%
EPS Next 3Y15.78%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.43%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-16.21%
Revenue Next Year-1.8%
Revenue Next 2Y-1.4%
Revenue Next 3Y0.78%
Revenue Next 5YN/A
EBIT growth 1Y-63.67%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year78.26%
EBIT Next 3Y15.88%
EBIT Next 5YN/A
FCF growth 1Y-17.3%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-11.57%
OCF growth 3Y12.73%
OCF growth 5Y0.25%